Skip to main content
ArticlePDF AVAILABLE

Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2?

Seminars in Arthritis and Rheumatism
DOI: 10.1016/j.semarthrit.2020.09.004
0Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

References Powered by Scopus

SARS-CoV-2 infection among patients with systemic autoimmune diseases

Autoimmunity Reviews
132Citations
N/AReaders
Get full text

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Seminars in Arthritis and Rheumatism
129Citations
N/AReaders
Get full text

Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients

Nefrologia
55Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Are glomerular patients treated with immunosupressed drugs more protected against sever SARS-Covid -2? (2020, December 1). Seminars in Arthritis and Rheumatism. W.B. Saunders. https://doi.org/10.1016/j.semarthrit.2020.09.004

Readers over time

‘20‘21‘22‘2402468

Readers' Seniority

Tooltip

Researcher 4

67%

PhD / Post grad / Masters / Doc 2

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Social Sciences 1

14%

Engineering 1

14%

Save time finding and organizing research with Mendeley

Sign up for free
0